Exact Mass: 760.367

Exact Mass Matches: 760.367

Found 80 metabolites which its exact mass value is equals to given mass value 760.367, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

(1R,4S,7S,10R,13R,16S)-13-(1H-Indol-3-ylmethyl)-4-(2-methylpropyl)-7-(2-methylsulfanylethyl)-16-(phenylmethyl)-3,6,9,12,15,18,20-heptazabicyclo[8.8.4]docosane-2,5,8,11,14,17,21-heptone

(1R,4S,7S,10R,13R,16S)-13-(1H-indol-3-Ylmethyl)-4-(2-methylpropyl)-7-(2-methylsulphanylethyl)-16-(phenylmethyl)-3,6,9,12,15,18,20-heptazabicyclo[8.8.4]docosane-2,5,8,11,14,17,21-heptone

C38H48N8O7S (760.3366)


   

PG(i-12:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15))

[(2S)-2,3-dihydroxypropoxy][(2R)-3-[(10-methylundecanoyl)oxy]-2-{[(5R,6R,7Z,9Z,11E,13E,15S,17Z)-5,6,15-trihydroxyicosa-7,9,11,13,17-pentaenoyl]oxy}propoxy]phosphinic acid

C38H65O13P (760.4163)


PG(i-12:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)) is an oxidized phosphatidylglycerol (PG). Oxidized phosphatidylglycerols are glycerophospholipids in which a phosphoglycerol moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidylglycerols can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PG(i-12:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)), in particular, consists of one chain of one 10-methylundecanoyl at the C-1 position and one chain of Lipoxin A5 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PGs can be synthesized via three different routes. In one route, the oxidized PG is synthetized de novo following the same mechanisms as for PGs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PG backbone, mainly through the action of LOX (PMID: 33329396).

   

PG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/i-12:0)

[(2S)-2,3-dihydroxypropoxy][(2R)-2-[(10-methylundecanoyl)oxy]-3-{[(5S,6S,7Z,9Z,11E,13E,15R,17Z)-5,6,15-trihydroxyicosa-7,9,11,13,17-pentaenoyl]oxy}propoxy]phosphinic acid

C38H65O13P (760.4163)


PG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/i-12:0) is an oxidized phosphatidylglycerol (PG). Oxidized phosphatidylglycerols are glycerophospholipids in which a phosphoglycerol moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidylglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidylglycerols can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/i-12:0), in particular, consists of one chain of one Lipoxin A5 at the C-1 position and one chain of 10-methylundecanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PGs can be synthesized via three different routes. In one route, the oxidized PG is synthetized de novo following the same mechanisms as for PGs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PG backbone, mainly through the action of LOX (PMID: 33329396).

   

Ipomoeassin B

Ipomoeassin B

C40H56O14 (760.367)


   

N-Demethylnicaustrine

(+)-N-Demethylnicaustrine

C42H52N2O11 (760.3571)


   
   
   
   

12-O-benzoylsarcostin 3-O-beta-D-oleandropyranosyl-(1->4)-beta-D-digitoxopyranoside|curassavosides B

12-O-benzoylsarcostin 3-O-beta-D-oleandropyranosyl-(1->4)-beta-D-digitoxopyranoside|curassavosides B

C41H60O13 (760.4034)


   

rehmaglutosides I

rehmaglutosides I

C36H56O17 (760.3517)


   
   

2-(O-beta-D-Glucopyranosyl)-16,25-diacetyl-cucurbitacine I

2-(O-beta-D-Glucopyranosyl)-16,25-diacetyl-cucurbitacine I

C40H56O14 (760.367)


   

3-O-{beta-D-galactopyranosyl-(1->2)-[beta-D-glucopyranosyl-(1->6)]-beta-D-glucopyranoside}-5alpha,14alpha-androst-8-ene

3-O-{beta-D-galactopyranosyl-(1->2)-[beta-D-glucopyranosyl-(1->6)]-beta-D-glucopyranoside}-5alpha,14alpha-androst-8-ene

C37H60O16 (760.3881)


   

LPIM1 18:1

2-O-(alpha-D-Manp)-(1-(9Z-octadecenoyl)-sn-glycero-3-phospho-1-myo-inositol)

C33H61O17P (760.3646)


   

2-O-Methyl Uridine CED Phosphoramidite

2-O-Methyl Uridine CED Phosphoramidite

C40H49N4O9P (760.3237)


DMT-2'O-Methyl-rU Phosphoramidite (2'-O-Me-U Phosphoramidite) is a 2'-O-Me derivative, and can be used for oligonucleotide synthesis[1][2].

   

(TETRAHYDRO-PYRAN-2-YL)ACETICACID

(TETRAHYDRO-PYRAN-2-YL)ACETICACID

C48H48MgN8 (760.3852)


   

(1R,4S,7S,10R,13R,16S)-13-(1H-Indol-3-ylmethyl)-4-(2-methylpropyl)-7-(2-methylsulfanylethyl)-16-(phenylmethyl)-3,6,9,12,15,18,20-heptazabicyclo[8.8.4]docosane-2,5,8,11,14,17,21-heptone

(1R,4S,7S,10R,13R,16S)-13-(1H-indol-3-Ylmethyl)-4-(2-methylpropyl)-7-(2-methylsulphanylethyl)-16-(phenylmethyl)-3,6,9,12,15,18,20-heptazabicyclo[8.8.4]docosane-2,5,8,11,14,17,21-heptone

C38H48N8O7S (760.3366)


   

PG(i-12:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15))

PG(i-12:0/20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15))

C38H65O13P (760.4163)


   

PG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/i-12:0)

PG(20:5(7Z,9Z,11E,13E,17Z)-3OH(5,6,15)/i-12:0)

C38H65O13P (760.4163)


   

N-{1-amino-6-[(5-nitro-2-furoyl)amino]-1-oxohexan-2-yl}-23-(indol-3-yl)-20-oxo-4,7,10,13,16-pentaoxa-19-azatricosan-1-amide

N-{1-amino-6-[(5-nitro-2-furoyl)amino]-1-oxohexan-2-yl}-23-(indol-3-yl)-20-oxo-4,7,10,13,16-pentaoxa-19-azatricosan-1-amide

C36H52N6O12 (760.3643)


   

oct-7-en-1-yl alpha-L-fucopyranosyl-(1->2)-[alpha-D-galactopyranosyl-(1->3)]-beta-D-galactopyranosyl-(1->3)-beta-D-galactopyranoside

oct-7-en-1-yl alpha-L-fucopyranosyl-(1->2)-[alpha-D-galactopyranosyl-(1->3)]-beta-D-galactopyranosyl-(1->3)-beta-D-galactopyranoside

C32H56O20 (760.3365)


   

oct-7-en-1-yl alpha-L-fucopyranosyl-(1->2)-[alpha-D-galactopyranosyl-(1->3)]-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranoside

oct-7-en-1-yl alpha-L-fucopyranosyl-(1->2)-[alpha-D-galactopyranosyl-(1->3)]-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranoside

C32H56O20 (760.3365)


   

5-aminopentyl alpha-L-rhamnopyranosyl-(1->4)-[beta-L-rhamnopyranosyl-(1->4)-beta-D-glucopyranosyl-(1->3)]-2-acetamido-2-deoxy-beta-D-galactopyranoside

5-aminopentyl alpha-L-rhamnopyranosyl-(1->4)-[beta-L-rhamnopyranosyl-(1->4)-beta-D-glucopyranosyl-(1->3)]-2-acetamido-2-deoxy-beta-D-galactopyranoside

C31H56N2O19 (760.3477)


   

[1-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-pentanoyloxypropan-2-yl] (12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoate

[1-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-pentanoyloxypropan-2-yl] (12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoate

C38H65O13P (760.4163)


   

[1-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-nonanoyloxypropan-2-yl] (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate

[1-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-nonanoyloxypropan-2-yl] (8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoate

C38H65O13P (760.4163)


   

[1-heptanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoate

[1-heptanoyloxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropan-2-yl] (10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoate

C38H65O13P (760.4163)


   

[1-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-undecanoyloxypropan-2-yl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

[1-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-undecanoyloxypropan-2-yl] (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate

C38H65O13P (760.4163)


   

[1-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-tridecanoyloxypropan-2-yl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

[1-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-tridecanoyloxypropan-2-yl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

C38H65O13P (760.4163)


   

[1-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-[(Z)-tridec-9-enoyl]oxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

[1-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-[(Z)-tridec-9-enoyl]oxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

C38H65O13P (760.4163)


   

[1-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-propanoyloxypropan-2-yl] (14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoate

[1-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxy-3-propanoyloxypropan-2-yl] (14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoate

C38H65O13P (760.4163)


   

[(2S)-3-[hydroxy-[(5S)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxy-2-undecanoyloxypropyl] (6E,9E,12E,15E)-octadeca-6,9,12,15-tetraenoate

[(2S)-3-[hydroxy-[(5S)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxy-2-undecanoyloxypropyl] (6E,9E,12E,15E)-octadeca-6,9,12,15-tetraenoate

C38H65O13P (760.4163)


   

[(2R)-1-[hydroxy-[(5R)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxy-3-undecanoyloxypropan-2-yl] (6E,9E,12E,15E)-octadeca-6,9,12,15-tetraenoate

[(2R)-1-[hydroxy-[(5R)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxy-3-undecanoyloxypropan-2-yl] (6E,9E,12E,15E)-octadeca-6,9,12,15-tetraenoate

C38H65O13P (760.4163)


   

[(2R)-1-[hydroxy-[(5R)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxy-3-undecanoyloxypropan-2-yl] (9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoate

[(2R)-1-[hydroxy-[(5R)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxy-3-undecanoyloxypropan-2-yl] (9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoate

C38H65O13P (760.4163)


   

[1-[hydroxy-[(5R)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxy-3-[(E)-tridec-8-enoyl]oxypropan-2-yl] (9E,11E,13E)-hexadeca-9,11,13-trienoate

[1-[hydroxy-[(5R)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxy-3-[(E)-tridec-8-enoyl]oxypropan-2-yl] (9E,11E,13E)-hexadeca-9,11,13-trienoate

C38H65O13P (760.4163)


   

[(2S)-3-[hydroxy-[(5S)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxy-2-undecanoyloxypropyl] (9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoate

[(2S)-3-[hydroxy-[(5S)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxy-2-undecanoyloxypropyl] (9E,11E,13E,15E)-octadeca-9,11,13,15-tetraenoate

C38H65O13P (760.4163)


   

[1-[hydroxy-[(5R)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxy-3-tridecanoyloxypropan-2-yl] (7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoate

[1-[hydroxy-[(5R)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxy-3-tridecanoyloxypropan-2-yl] (7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoate

C38H65O13P (760.4163)


   

LPIM1(18:1(9Z)/0:0)

LPIM1(18:1(9Z)/0:0)

C33H61O17P (760.3646)


   
   
   

PG 20:2/12:3;O3

PG 20:2/12:3;O3

C38H65O13P (760.4163)


   

PG 20:3/12:2;O3

PG 20:3/12:2;O3

C38H65O13P (760.4163)


   
   
   

PI P-16:1/13:3;O

PI P-16:1/13:3;O

C38H65O13P (760.4163)


   

PI P-18:1/11:3;O

PI P-18:1/11:3;O

C38H65O13P (760.4163)


   
   
   
   
   
   
   
   
   
   
   
   

(8r)-8-ethyl-1,6,8,11-tetrahydroxy-10-{[5-({4-hydroxy-5-[(5-hydroxy-6-methyloxan-2-yl)oxy]-6-methyloxan-2-yl}oxy)-6-methyloxan-2-yl]oxy}-7-(hydroxymethyl)-7,9,10,11a-tetrahydro-5ah-tetracene-5,12-dione

(8r)-8-ethyl-1,6,8,11-tetrahydroxy-10-{[5-({4-hydroxy-5-[(5-hydroxy-6-methyloxan-2-yl)oxy]-6-methyloxan-2-yl}oxy)-6-methyloxan-2-yl]oxy}-7-(hydroxymethyl)-7,9,10,11a-tetrahydro-5ah-tetracene-5,12-dione

C39H52O15 (760.3306)


   

(2s)-n-[(3s,6s,9r,10s,13r,18as)-13-benzyl-1,4,11-trihydroxy-3,6-diisopropyl-9-methyl-7,14-dioxo-3h,6h,9h,10h,13h,16h,17h,18h,18ah-pyrrolo[2,1-i]1-oxa-4,7,10,13-tetraazacyclohexadecan-10-yl]-2-[(1-hydroxy-2-phenylethylidene)amino]-3-methylbutanimidic acid

(2s)-n-[(3s,6s,9r,10s,13r,18as)-13-benzyl-1,4,11-trihydroxy-3,6-diisopropyl-9-methyl-7,14-dioxo-3h,6h,9h,10h,13h,16h,17h,18h,18ah-pyrrolo[2,1-i]1-oxa-4,7,10,13-tetraazacyclohexadecan-10-yl]-2-[(1-hydroxy-2-phenylethylidene)amino]-3-methylbutanimidic acid

C41H56N6O8 (760.4159)


   

(1s,3r,4s,5r,6r,8r,10s,23r,24s,25r,26r)-4,5,26-trihydroxy-6-methyl-17,20-dioxo-24-{[(2e)-3-phenylprop-2-enoyl]oxy}-10-propyl-2,7,9,21,27-pentaoxatricyclo[21.3.1.0³,⁸]heptacosan-25-yl (2e)-2-methylbut-2-enoate

(1s,3r,4s,5r,6r,8r,10s,23r,24s,25r,26r)-4,5,26-trihydroxy-6-methyl-17,20-dioxo-24-{[(2e)-3-phenylprop-2-enoyl]oxy}-10-propyl-2,7,9,21,27-pentaoxatricyclo[21.3.1.0³,⁸]heptacosan-25-yl (2e)-2-methylbut-2-enoate

C40H56O14 (760.367)


   

(2r,3r,5r)-2-[(1s,3as,5ar,7r,8s,9ar,9br,11ar)-3a,7,8-tris(acetyloxy)-9a,11a-dimethyl-5-oxo-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-2,6-bis(acetyloxy)-5-ethyl-6-methylheptan-3-yl acetate

(2r,3r,5r)-2-[(1s,3as,5ar,7r,8s,9ar,9br,11ar)-3a,7,8-tris(acetyloxy)-9a,11a-dimethyl-5-oxo-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-2,6-bis(acetyloxy)-5-ethyl-6-methylheptan-3-yl acetate

C41H60O13 (760.4034)


   

(2z,4e,6s,8r,9z,12r,19z,21e,23s,24r,25z,28s)-23,24-dihydroxy-12,28-bis[(3s,4e)-3-hydroxy-2-methylhex-4-en-2-yl]-7,13,17,29,33-pentaoxa-34,35-diazatetracyclo[29.2.1.1¹⁵,¹⁸.0⁶,⁸]pentatriaconta-1(34),2,4,9,15,18(35),19,21,25,31-decaene-14,30-dione

(2z,4e,6s,8r,9z,12r,19z,21e,23s,24r,25z,28s)-23,24-dihydroxy-12,28-bis[(3s,4e)-3-hydroxy-2-methylhex-4-en-2-yl]-7,13,17,29,33-pentaoxa-34,35-diazatetracyclo[29.2.1.1¹⁵,¹⁸.0⁶,⁸]pentatriaconta-1(34),2,4,9,15,18(35),19,21,25,31-decaene-14,30-dione

C42H52N2O11 (760.3571)


   

(2r,3r,4s,5s,6r)-2-{[(2r,3s,4s,5r,6r)-6-{[(3ar,5as,7s,9as,11as)-9a,11a-dimethyl-1h,2h,3h,3ah,4h,5h,5ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-3,4-dihydroxy-5-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(2r,3s,4s,5r,6r)-6-{[(3ar,5as,7s,9as,11as)-9a,11a-dimethyl-1h,2h,3h,3ah,4h,5h,5ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-yl]oxy}-3,4-dihydroxy-5-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C37H60O16 (760.3881)


   

(1s,3s,4r,5s,6s,8s,10s,23s,24r,25r,26r)-4,5,26-trihydroxy-6-methyl-17,20-dioxo-24-{[(2e)-3-phenylprop-2-enoyl]oxy}-10-propyl-2,7,9,21,27-pentaoxatricyclo[21.3.1.0³,⁸]heptacosan-25-yl (2z)-2-methylbut-2-enoate

(1s,3s,4r,5s,6s,8s,10s,23s,24r,25r,26r)-4,5,26-trihydroxy-6-methyl-17,20-dioxo-24-{[(2e)-3-phenylprop-2-enoyl]oxy}-10-propyl-2,7,9,21,27-pentaoxatricyclo[21.3.1.0³,⁸]heptacosan-25-yl (2z)-2-methylbut-2-enoate

C40H56O14 (760.367)


   

(3e,6r)-6-[(1r,2r,3as,3bs,9ar,9br,11ar)-2-(acetyloxy)-3a,6,6,9b,11a-pentamethyl-7,10-dioxo-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,9ah,11h-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl acetate

(3e,6r)-6-[(1r,2r,3as,3bs,9ar,9br,11ar)-2-(acetyloxy)-3a,6,6,9b,11a-pentamethyl-7,10-dioxo-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,9ah,11h-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl acetate

C40H56O14 (760.367)


   

n-{13-benzyl-1,4,11-trihydroxy-3,6-diisopropyl-9-methyl-7,14-dioxo-3h,6h,9h,10h,13h,16h,17h,18h,18ah-pyrrolo[2,1-i]1-oxa-4,7,10,13-tetraazacyclohexadecan-10-yl}-2-[(1-hydroxy-2-phenylethylidene)amino]-3-methylbutanimidic acid

n-{13-benzyl-1,4,11-trihydroxy-3,6-diisopropyl-9-methyl-7,14-dioxo-3h,6h,9h,10h,13h,16h,17h,18h,18ah-pyrrolo[2,1-i]1-oxa-4,7,10,13-tetraazacyclohexadecan-10-yl}-2-[(1-hydroxy-2-phenylethylidene)amino]-3-methylbutanimidic acid

C41H56N6O8 (760.4159)


   

2-[3a,7,8-tris(acetyloxy)-9a,11a-dimethyl-5-oxo-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-2,6-bis(acetyloxy)-5-ethyl-6-methylheptan-3-yl acetate

2-[3a,7,8-tris(acetyloxy)-9a,11a-dimethyl-5-oxo-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-2,6-bis(acetyloxy)-5-ethyl-6-methylheptan-3-yl acetate

C41H60O13 (760.4034)


   

2-{[6-({9a,11a-dimethyl-1h,2h,3h,3ah,4h,5h,5ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-yl}oxy)-3,4-dihydroxy-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

2-{[6-({9a,11a-dimethyl-1h,2h,3h,3ah,4h,5h,5ah,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-7-yl}oxy)-3,4-dihydroxy-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methoxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C37H60O16 (760.3881)


   

(1s,4ar,5r,7s,7as)-7-hydroxy-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-5-yl (2e,4e)-5-[(1r,6r)-1-hydroxy-2,2,6-trimethyl-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclohexyl]-3-methylpenta-2,4-dienoate

(1s,4ar,5r,7s,7as)-7-hydroxy-7-methyl-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-5-yl (2e,4e)-5-[(1r,6r)-1-hydroxy-2,2,6-trimethyl-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclohexyl]-3-methylpenta-2,4-dienoate

C36H56O17 (760.3517)


   

23,24-dihydroxy-12,28-bis(3-hydroxy-2-methylhex-4-en-2-yl)-7,13,17,29,33-pentaoxa-34,35-diazatetracyclo[29.2.1.1¹⁵,¹⁸.0⁶,⁸]pentatriaconta-1(34),2,4,9,15,18(35),19,21,25,31-decaene-14,30-dione

23,24-dihydroxy-12,28-bis(3-hydroxy-2-methylhex-4-en-2-yl)-7,13,17,29,33-pentaoxa-34,35-diazatetracyclo[29.2.1.1¹⁵,¹⁸.0⁶,⁸]pentatriaconta-1(34),2,4,9,15,18(35),19,21,25,31-decaene-14,30-dione

C42H52N2O11 (760.3571)


   

2',10',13'-tris(acetyloxy)-8',12',15',15'-tetramethyl-5'-{[3-(methylamino)-3-phenylpropanoyl]oxy}spiro[oxirane-2,4'-tricyclo[9.3.1.0³,⁸]pentadecan]-11'-en-9'-yl pyridine-3-carboxylate

2',10',13'-tris(acetyloxy)-8',12',15',15'-tetramethyl-5'-{[3-(methylamino)-3-phenylpropanoyl]oxy}spiro[oxirane-2,4'-tricyclo[9.3.1.0³,⁸]pentadecan]-11'-en-9'-yl pyridine-3-carboxylate

C42H52N2O11 (760.3571)


   

(2z,4z,9z,19z,21z,25z)-23,24-dihydroxy-12,28-bis[(4e)-3-hydroxy-2-methylhex-4-en-2-yl]-7,13,17,29,33-pentaoxa-34,35-diazatetracyclo[29.2.1.1¹⁵,¹⁸.0⁶,⁸]pentatriaconta-1(34),2,4,9,15,18(35),19,21,25,31-decaene-14,30-dione

(2z,4z,9z,19z,21z,25z)-23,24-dihydroxy-12,28-bis[(4e)-3-hydroxy-2-methylhex-4-en-2-yl]-7,13,17,29,33-pentaoxa-34,35-diazatetracyclo[29.2.1.1¹⁵,¹⁸.0⁶,⁸]pentatriaconta-1(34),2,4,9,15,18(35),19,21,25,31-decaene-14,30-dione

C42H52N2O11 (760.3571)


   

(1r,2s,4r,5r,6r,7s,9r,10s,11s,12r,13r,14r,15s,22r,23s,25s)-12-(benzoyloxy)-10,11,22-trihydroxy-9-(hydroxymethyl)-13,15-dimethyl-4-(prop-1-en-2-yl)-8,24,26,27-tetraoxaheptacyclo[12.10.1.1⁴,²³.1⁵,²³.0¹,⁶.0⁷,⁹.0¹¹,²⁵]heptacosan-2-yl benzoate

(1r,2s,4r,5r,6r,7s,9r,10s,11s,12r,13r,14r,15s,22r,23s,25s)-12-(benzoyloxy)-10,11,22-trihydroxy-9-(hydroxymethyl)-13,15-dimethyl-4-(prop-1-en-2-yl)-8,24,26,27-tetraoxaheptacyclo[12.10.1.1⁴,²³.1⁵,²³.0¹,⁶.0⁷,⁹.0¹¹,²⁵]heptacosan-2-yl benzoate

C43H52O12 (760.3459)


   

(1s,3r,4s,5r,6r,8r,10s,23r,24r,25r,26r)-4,5,26-trihydroxy-6-methyl-17,20-dioxo-24-{[(2e)-3-phenylprop-2-enoyl]oxy}-10-propyl-2,7,9,21,27-pentaoxatricyclo[21.3.1.0³,⁸]heptacosan-25-yl (2e)-2-methylbut-2-enoate

(1s,3r,4s,5r,6r,8r,10s,23r,24r,25r,26r)-4,5,26-trihydroxy-6-methyl-17,20-dioxo-24-{[(2e)-3-phenylprop-2-enoyl]oxy}-10-propyl-2,7,9,21,27-pentaoxatricyclo[21.3.1.0³,⁸]heptacosan-25-yl (2e)-2-methylbut-2-enoate

C40H56O14 (760.367)


   

(1'r,2r,2'r,3'r,5's,8'r,9'r,10'r,13's)-2',10',13'-tris(acetyloxy)-8',12',15',15'-tetramethyl-5'-{[(3r)-3-(methylamino)-3-phenylpropanoyl]oxy}spiro[oxirane-2,4'-tricyclo[9.3.1.0³,⁸]pentadecan]-11'-en-9'-yl pyridine-3-carboxylate

(1'r,2r,2'r,3'r,5's,8'r,9'r,10'r,13's)-2',10',13'-tris(acetyloxy)-8',12',15',15'-tetramethyl-5'-{[(3r)-3-(methylamino)-3-phenylpropanoyl]oxy}spiro[oxirane-2,4'-tricyclo[9.3.1.0³,⁸]pentadecan]-11'-en-9'-yl pyridine-3-carboxylate

C42H52N2O11 (760.3571)


   

[(1s,2r,3s,7s,8r,10r,11r,15s,16s,17s)-3,17-bis(acetyloxy)-15-(furan-3-yl)-10-[(2-hydroxy-3-methylbutanoyl)oxy]-2,7,16-trimethyl-5-oxo-6-oxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadec-12-en-7-yl]methyl 2,3-dihydroxy-3-methylpentanoate

[(1s,2r,3s,7s,8r,10r,11r,15s,16s,17s)-3,17-bis(acetyloxy)-15-(furan-3-yl)-10-[(2-hydroxy-3-methylbutanoyl)oxy]-2,7,16-trimethyl-5-oxo-6-oxatetracyclo[9.7.0.0²,⁸.0¹²,¹⁶]octadec-12-en-7-yl]methyl 2,3-dihydroxy-3-methylpentanoate

C40H56O14 (760.367)


   

4,5,26-trihydroxy-6-methyl-17,20-dioxo-24-[(3-phenylprop-2-enoyl)oxy]-10-propyl-2,7,9,21,27-pentaoxatricyclo[21.3.1.0³,⁸]heptacosan-25-yl 2-methylbut-2-enoate

4,5,26-trihydroxy-6-methyl-17,20-dioxo-24-[(3-phenylprop-2-enoyl)oxy]-10-propyl-2,7,9,21,27-pentaoxatricyclo[21.3.1.0³,⁸]heptacosan-25-yl 2-methylbut-2-enoate

C40H56O14 (760.367)


   

6-[2-(acetyloxy)-3a,6,6,9b,11a-pentamethyl-7,10-dioxo-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,9ah,11h-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl acetate

6-[2-(acetyloxy)-3a,6,6,9b,11a-pentamethyl-7,10-dioxo-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,2h,3h,3bh,4h,9ah,11h-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl acetate

C40H56O14 (760.367)


   

21-(1-hydroxyethyl)-11,24-diisopropyl-4,18-bis(sec-butyl)-6-oxa-13,26-dithia-3,10,17,20,23,28,29,30-octaazatetracyclo[23.2.1.1⁵,⁸.1¹²,¹⁵]triaconta-1(27),2,5(30),9,12(29),14,16,19,22,25(28)-decaene-2,9,16,19,22-pentol

21-(1-hydroxyethyl)-11,24-diisopropyl-4,18-bis(sec-butyl)-6-oxa-13,26-dithia-3,10,17,20,23,28,29,30-octaazatetracyclo[23.2.1.1⁵,⁸.1¹²,¹⁵]triaconta-1(27),2,5(30),9,12(29),14,16,19,22,25(28)-decaene-2,9,16,19,22-pentol

C35H52N8O7S2 (760.34)


   

12-(benzoyloxy)-10,11,22-trihydroxy-9-(hydroxymethyl)-13,15-dimethyl-4-(prop-1-en-2-yl)-8,24,26,27-tetraoxaheptacyclo[12.10.1.1⁴,²³.1⁵,²³.0¹,⁶.0⁷,⁹.0¹¹,²⁵]heptacosan-2-yl benzoate

12-(benzoyloxy)-10,11,22-trihydroxy-9-(hydroxymethyl)-13,15-dimethyl-4-(prop-1-en-2-yl)-8,24,26,27-tetraoxaheptacyclo[12.10.1.1⁴,²³.1⁵,²³.0¹,⁶.0⁷,⁹.0¹¹,²⁵]heptacosan-2-yl benzoate

C43H52O12 (760.3459)